Researchers advise caution when using Abbott’s MitraClip device during transcatheter edge-to-edge repair (TEER) procedures, a new study of over 5,000 adverse event reports concludes.
The paper was published 18 January in JACC: Cardiovascular Interventions. Researchers explored national MitraClip outcomes through the US Food and Drug Administration’s
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?